Skip to content

Captopril/Hydrochlorothiazide

    DEA Class; Rx

    Common Brand Names; Capozide

    • ACEI/Diuretic Combos; 
    • ACEI/HCTZ Combos

    Combination ACE inhibitor and thiazide diuretic; usually given 2—3 times daily; additive efficacy in HTN; counters the potassium loss from HCTZ; more effective than ACE monotherapy in black patients; captopril contains a sulfhydryl group and is shortest-acting.

    Indicated for the treatment of hypertension.

    Hypersensitivity to either component or sulfonamides

    History of hereditary or idiopathic angioedema

    Coadministration of neprilysin inhibitors (eg, sacubitril) with ACE inhibitors may increase angioedema risk; do not administer ACE inhibitors within 36 hr of switching to or from sacubitril/valsartan

    Bilateral renal artery stenosis or anuria

    Do not coadminister with aliskiren in patients with diabetes

    Captopril

    • Chest pain (1%)
    • Cough (1-2%)
    • Dysgeusia (2-4%)
    • Hypersensitivity reactions
    • Hyperkalemia (1-11%)
    • Hypotension (1-3%)
    • Palpitations (1%)
    • Pruritis rash (2%)
    • Tachycardia (1%)
    • Angioedema
    • ARF if renal artery stenosis
    • Impotence
    • Neutropenia
    • Photosensitivity
    • Orthostatic hypotension, ataxia, angioedema, cardiac arrest, CHF, rhythm disturbances, somnolence, confusion, nervousness, depression, Stevens-Johnson syndrome, exfoliative dermatitis, bullous pemphigus, increased billirubin, gynecomastia, increased alkaline phosphatase, dyspepsia, pancreatitis, glossitis, impotence, urinary frequency, agranulocytosis anemia, thrombocytopenia, anemia, pancytopenia, blurred vision, bronchospasm, eosinophilic pneumonitis, rhinitis, cholestasis, hyponatremia

    Hydrochlorothiazide

    • Anaphylaxis, anemia, confusion, erythema multiforme skin reactions including Stevens-Johnson syndrome, exfoliative dermatitis including toxic epidermal necrolysis, hypomagnesemia, hyponatremia, hypochloremia, dizziness, fatigue, headache, hypercalcemia, hyperuricemia, hyperglycemia, hyperlipidemia, hypercholesterolemia, muscle weakness or cramps, nausea, purpura, rash, vertigo, vomiting
    • Anorexia
    • Epigastric distress
    • Hypotension
    • Orthostatic hypotension
    • Photosensitivity

    Excessive hypotension if concomitant diuretics, hypovolemia, hyponatremia

    Risk of hyperkalemia, especially in patients with renal impairment, DM or those taking concomitant K+-elevating drugs

    Dual blockade of the renin angiotensin system with ARBs, ACE inhibitors, or aliskiren associated with increased risk for hypotension, hyperkalemia, and renal function changes (including acute renal failure) compared to monotherapy

    DM, fluid or electrolyte imbalance, hyperuricemia or gout, SLE, liver disease, renal disease

    May aggravate digitalis toxicity

    Sensitivity reactions may occur with or without history of allergy or asthma

    Aortic stenosis/ hypertrophic cardiomyopathy

    Biliary cirrhosis or biliary obstruction

    Myelosuppression

    Blood levels do not correlate with BP response

    Causes false positive urine acetone

    Risk of male sexual dysfunction

    Avoid concomitant use with lithium

    Acute transient myopia and acute angle-closure glaucoma has been reported, particularly with history of sulfonamide or penicillin allergy (hydrochlorothiazide is a sulfonamide)

    Pregnancy Category: C (1st trimester); D (2nd and 3rd trimester)

    Lactation: excreted in breast milk, use caution

    Adults

    150 mg/day PO captopril and 50 mg/day PO hydrochlorothiazide.

    Geriatric

    150 mg/day PO captopril and 50 mg/day PO hydrochlorothiazide.

    Adolescents

    150 mg/day PO captopril and 50 mg/day PO hydrochlorothiazide.

    Children

    Maximum dosage information is not available for the combination product.

    Captopril/hydrochlorothiazide

    tablet

    • 25mg/15mg
    • 25mg/25mg
    • 50mg/15mg
    • 50mg/25mg